患有非传染性疾病的人使用阿育吠陀:一项基于英国的定性研究
Patricia Egwumba1, Kaushik Chattopadhyay1,2, Laura Nellums3
1Lifespan and Population Health, School of Medicine, University of Nottingham, UK.
概括
在英国,患有非传染性疾病 (NCD) 的人因其自然,整体的方法而使用阿育吠陀. 尽管面临成本和产品安全等挑战,他们发现它是一种有价值的补充疗法,用于管理他们的情况.
科学领域:
- 综合医学是一个整体医学.
- 补充和替代医学 (CAM)
- 公共卫生 公共卫生
背景情况:
- 非传染性疾病 (NCD) 是英国的主要健康问题,给国家卫生服务 (NHS) 带来了压力.
- 阿育吠陀对于非传染性疾病管理越来越受欢迎,但其在英国的使用研究不足.
- 这项研究调查了使用阿育吠陀的英国非传染性疾病患者的经验.
研究的目的:
- 探索英国使用阿育吠陀的非传染性疾病患者的经验和观点.
- 了解选择阿育吠陀的动机和感知到的好处.
- 确定在获得和维持阿育吠陀治疗方面面临的挑战.
主要方法:
- 质量研究涉及20个半结构面试.
- 参与者是英国成年人,被诊断患有非传染性疾病.
- 用专题分析来分析采访成绩单.
主要成果:
- 参与者更喜欢阿育吠陀,因为它的自然,整体的哲学和对传统医学的副作用和不个人性质的不满.
- 积极的经验包括个性化咨询,多种治疗方法和改善的健康结果.
- 挑战包括对产品安全的担忧,复杂的治疗方案,有限的可用性和缺乏NHS覆盖.
结论:
- 艾尔维达被视为一种自然的,哲学上的治愈系统,由英国非传染性疾病的个人.
- 尽管存在结构和财务障碍,阿育吠陀被认为是相关的NCD管理选项.
- 阿育吠陀仍然是英国非传染性疾病管理的重要补充方法.
更多相关视频
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
11.3K
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
695
相关概念视频
01:18Factors Affecting Illness
5.4K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
5.4K
01:24Chronic Obstructive Pulmonary Disease
3.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
1.9K
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.9K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
252
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
252
01:23Chronic Obstructive Pulmonary Disease I: Introduction
71
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
71